April 13, 2018 (v1)
Journal article
Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia
Achondroplasia is a rare genetic disease is characterized by abnormal bone development and early obesity. While the bone aspect of the disease has been thoroughly studied, early obesity affecting approximately 50% of them during childhood has been somewhat neglected. It nevertheless represents a major health problem in these patients, and is...
Uploaded on: March 10, 2024